Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.23.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2023
Mar. 31, 2022
Current assets:    
Cash and cash equivalents $ 25,963 $ 5,210
Restricted cash 212 283
Accounts receivable, net of allowance for doubtful accounts of $201 and $422, respectively 72,464 69,354
Manufacturing inventories 19,441 33,546
Service parts inventories 25,304 24,254
Prepaid expenses 4,158 7,853
Other current assets 5,513 4,697
Total current assets 153,055 145,197
Property and equipment, net 16,555 12,853
Intangible assets, net 4,941 9,584
Goodwill 12,969 12,969
Right-of-use assets, net 10,291 11,107
Other long-term assets 15,846 9,925
Total assets 213,657 201,635
Current liabilities:    
Accounts payable 35,716 34,220
Deferred revenue, current portion 82,504 86,517
Long-term debt, current portion 5,000 4,375
Accrued compensation 15,710 16,141
Other accrued liabilities 13,666 16,562
Total current liabilities 152,596 157,815
Deferred revenue, net of current portion 43,306 41,580
Revolving credit facility 16,750 17,735
Term loan 66,354 89,448
Operating lease liabilities 10,169 9,891
Other long-term liabilities 11,370 11,849
Total liabilities 300,545 328,318
Commitments and Contingencies (Note 11)
Preferred stock:    
Preferred stock, 20,000 shares authorized; no shares issued as of March 31, 2023 and 2022 0 0
Common stock:    
Common stock, $0.01 par value; 225,000 shares authorized; 93,574 and 60,433 shares issued and outstanding at March 31, 2023 and 2022, respectively 936 605
Additional paid-in capital 722,603 645,038
Accumulated deficit (808,846) (770,903)
Accumulated other comprehensive loss (1,581) (1,423)
Total stockholders' deficit (86,888) (126,683)
Total liabilities and stockholders' deficit $ 213,657 $ 201,635